Polynucleotide encoding human netrin-1

US6218526A · kind A · utility

Assignees

• The Regents of the University of California · US
• Exelixis Pharmaceuticals, Inc. · US

Inventors

• Candace Swimmer · San Francisco, US
• Anne Shyjan · Nahant, US
• David Leonardo · Mill Valley, US
• Yuan-Peng Zhang · Mountain View, US
• Timothy Kennedy · Montréal, CA
• Tito Serafini · San Francisco, US
• Marc Tessier-Lavigne · San Mateo, US

Key dates

• Filing date: Aug 20, 1998
• Grant date: Apr 17, 2001
• Expiry date: Aug 20, 2018

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Specific netrin proteins, nucleic acids which encode netrin proteins and hybridization reagents, probes and primers capable of hybridizing with netrin genes and methods for screening chemical libraries for lead compounds for pharmacological agents useful in the diagnosis or treatment of disease associated undesirable cell growth are provided. An exemplary screen involves forming a mixture comprising a recombinant netrin protein, a natural intracellular netrin protein binding target, and a candidate pharmacological agent; incubating the mixture under conditions whereby, but for the presence of said candidate pharmacological agent, said netrin protein selectively binds said binding target; and detecting the presence or absence of specific binding of said netrin protein to said binding target.